"Indefinite for dysplasia" microdissected targets tended to have higher mutation load than those with intestinal metaplasia, with mutations detected in 86% of microdissected targets (Table 4).
Together, these clinical, genetic, and pathological findings confirmed a NPARM PHOX2B mutation and diagnosis of CCHS with intestinal aganglionosis.
These results illustrate that high-throughput mass spectrometry-based metabolomics combined with appropriate statistical modeling and large scale functional metabolomics approaches can be used to investigate complex environment-gene interactions, such as a combined diet-mutation effect, and their association with intestinal polyposis and tumorigenesis.
Thus we suggest to specifically include reactivated and opportunistic infections in the differential diagnosis of suspected catheter related infection in patients with intestinal failure who carry mutations in their NOD2 gene.
As with intestinal metaplasia, some "indefinite for dysplasia" microdissected targets may have mutations that precede morphological changes consistent with dysplasia.
We detected the CDH1 mutations D402H and A408V in diffuse-type signet cell ring gastric carcinomas, confirming previous observations that CDH1 mutations are associated with diffuse- or mixed-type gastric cancer but not with intestinal gastric carcinoma [ 32].
We propose that patients with intestinal atresia, isolated diastasis recti, or umbilical hernia should be screened for mutations and deletions in FOXL1.
Sox2 mutations are associated with esophageal atresia in anophthalmia-esophageal-genital syndrome [ 29], and its down-regulation is associated with intestinal metaplasia in the stomach [ 30, 31].
She was diagnosed with intestinal cancer in February 1953.
With the Pollock, I knew that I wanted it squirming with intestinal motion.
